规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50μL*10mM(DMSO) | ¥99随货¥69 | 咨询 | |
100μL*10mM(DMSO) | ¥139随货¥99 | 咨询 | |
250μL*10mM(DMSO) | ¥259随货¥189 | 咨询 | |
500μL*10mM(DMSO) | ¥369随货¥259 | 咨询 | |
10mM*1mL(DMSO) | ¥518 | 咨询 | |
5mg | ¥264 | 咨询 | |
10mg | ¥422 | 咨询 | |
25mg | ¥850 | 咨询 | |
50mg | ¥1449 | 咨询 |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Carbonic Anhydrase ↓ ↑ | Carbonic Anhydrase I ↓ ↑ | Carbonic Anhydrase II ↓ ↑ | Carbonic Anhydrase IV ↓ ↑ | Carbonic Anhydrase IX ↓ ↑ | Carbonic Anhydrase XII ↓ ↑ | 其他靶点 | 纯度 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Topiramate | ✔ | Calcium Channel | 98% | ||||||||||||||||
Dichlorphenamide | ✔ | 98% | |||||||||||||||||
Mafenide Acetate | ✔ | 98% | |||||||||||||||||
Benzenesulphonamide | ✔ | 98% | |||||||||||||||||
Dorzolamide HCl |
+
Carbonic anhydrase I, Ki: 6000 nM |
++++
Carbonic anhydrase II, Ki: 1.9 nM |
+++
Carbonic anhydrase IV, Ki: 31 nM | 98% | |||||||||||||||
Methazolamide |
++
hCAI, Ki: 50 nM |
+++
hCAII, Ki: 14 nM |
++
bCAIV, Ki: 36 nM | 98% | |||||||||||||||
Tioxolone |
+
CAI, Ki: 91 nM | 98% | |||||||||||||||||
U-104 |
++
CAIX, Ki: 45.1 nM |
++++
CAXII, Ki: 4.5 nM | 98% | ||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Methyclothiazide is a substituted benzothiadiazide, used to treat high blood pressure and fluid retention caused by various conditions including heart disease. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00208429 | Rheumatoid Arthritis ... 展开 >> Osteoarthritis Post-traumatic Arthritis Collagen Disorders Avascular Necrosis Traumatic Femoral Fractures Nonunion of Femoral Fractures Congenital Hip Dysplasia Slipped Capital Femoral Epiphysis 收起 << | Phase 4 | Withdrawn(Site Principal Inves... 展开 >>tigator became seriously ill, so study abandoned before the start of recruitment) 收起 << | July 1, 2019 | - |
NCT01121146 | Osteoarthritis ... 展开 >> Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases 收起 << | Not Applicable | Completed | - | United States, Virginia ... 展开 >> Anderson Orthopaedic Research Institute Alexandria, Virginia, United States, 22306 收起 << |
NCT00208442 | Osteoarthritis ... 展开 >> Post-traumatic Arthritis Collagen Disorders Avascular Necrosis Traumatic Femoral Fractures Nonunion of Femoral Fractures Congenital Hip Dysplasia Slipped Capital Femoral Epiphysis 收起 << | Phase 4 | Completed | - | New Zealand ... 展开 >> University Otago, Wellington Medical School of Medicine Wellington, New Zealand 收起 << |
计算器 | ||||
存储液制备 | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 2.78mL 0.56mL 0.28mL | 13.88mL 2.78mL 1.39mL | 27.76mL 5.55mL 2.78mL |
CAS号 | 135-07-9 |
分子式 | C9H11Cl2N3O4S2 |
分子量 | 360.237 |
别名 | NSC 110431 |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,2-8°C |
溶解方案 | DMSO: 75 mg/mL(208.2 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |